Pulmonary drug delivery (AlphazerTM) > Description of our technology
Omega Life Science developed a pulmonary drug delivery system for systemic and local targeting, consisting of a propriety inhaler and a tailor-made formulation technology.
The inhaler employs our ability to produce sub-micron droplets and sub-micron to nano- sized dry particles (link to Description of our Technology).
The formulation capability is based on our nano-particles production technology (link to Description of our Technology) which enables preparation of nano-suspension or improved-solubility API to be used in the inhaler.
Website Design by Hoojima